Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 EUR | -1.27% | -.--% | -8.24% |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
Quotes 5-day view
Real-time Euronext Bruxelles2024-05-24 | 2024-05-27 | 2024-05-28 | 2024-05-29 | |
---|---|---|---|---|
Last | 11.7 € | 11.7 € | 11.7 € | 11.7 € |
Change | -.--% | -.--% | -.--% | -.--% |
Performance
1 day | -1.27% | ||
3 months | -4.49% | ||
6 months | -6.40% | ||
Current year | -8.24% | ||
1 year | +1.74% | ||
3 years | -17.89% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-1.27% | -.--% | -8.24% | +1.74% | 354M | ||
+0.45% | +1.07% | +39.22% | +90.59% | 731B | ||
+1.50% | -1.26% | +32.59% | +65.88% | 586B | ||
+0.04% | -5.90% | -7.85% | -6.42% | 348B | ||
-0.15% | -3.97% | +15.48% | +13.35% | 319B | ||
-0.35% | -3.02% | -0.12% | +12.53% | 273B | ||
+0.78% | -3.03% | +13.47% | +4.61% | 235B | ||
+0.76% | -1.56% | +7.60% | +4.94% | 202B | ||
-1.07% | -2.20% | -7.16% | -21.15% | 203B | ||
-1.70% | -6.01% | -3.37% | -26.01% | 158B | ||
+0.49% | -2.25% | -1.82% | -6.55% | 119B | ||
-0.49% | -2.19% | +19.91% | +26.84% | 90.55B | ||
-0.59% | -4.94% | -21.56% | -36.93% | 81.59B | ||
-0.68% | -6.33% | -21.61% | -17.62% | 79.11B | ||
-0.97% | +0.41% | +39.44% | +18.14% | 66.34B | ||
-.--% | +1.73% | - | - | 63.66B | ||
Average | -0.05% | -2.73% | +6.40% | +8.26% | ||
Weighted average by Cap. | +0.21% | -2.25% | +15.29% | +29.33% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -8.24% | ||
2023 | +9.91% | ||
2022 | -32.95% | ||
2021 | +82.11% | ||
2020 | -8.57% |
- Stock Market
- Equities
- HYL Stock
- Quotes Hyloris Pharmaceuticals SA